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Abstract
Objectives: Recently, an increasing number of systematic reviews have been published in which the measurement properties of health
status questionnaires are compared. For a meaningful comparison, quality criteria for measurement properties are needed. Our aim was to
develop quality criteria for design, methods, and outcomes of studies on the development and evaluation of health status questionnaires.
Study Design and Setting: Quality criteria for content validity, internal consistency, criterion validity, construct validity, reproducibil-
ity, longitudinal validity, responsiveness, floor and ceiling effects, and interpretability were derived from existing guidelines and consensus
within our research group.
Results: For each measurement property a criterion was defined for a positive, negative, or indeterminate rating, depending on the de-
sign, methods, and outcomes of the validation study.
Conclusion: Our criteria make a substantial contribution toward defining explicit quality criteria for measurement properties of health
status questionnaires. Our criteria can be used in systematic reviews of health status questionnaires, to detect shortcomings and gaps in
knowledge of measurement properties, and to design validation studies. The future challenge will be to refine and complete the criteria
and to reach broad consensus, especially on quality criteria for good measurement properties.  2006 Elsevier Inc. All rights reserved.
Keywords: Reproducibility; Reliability; Validity; Responsiveness; Guidelines; Criteria1. Introduction
The number of available health status questionnaires has
increased dramatically over the past decades. Consequently,
the choice of which questionnaire to use is becoming a
major difficulty. Recently a large number of systematic
reviews have been published of available questionnaires
measuring a specific concept in a specific population, for
example [1e11]. In these systematic reviews, typically,
the content and measurement properties of the available
questionnaires are compared. In analogy to systematic
reviews of clinical trials, criteria are needed to determine
the methodological quality of studies on the development
and evaluation of health status questionnaires. In addition,
* Corresponding author. Tel.: þ31-20-4448187; fax: þ31-20-4446775.
E-mail address: cb.terwee@vumc.nl (C.B. Terwee).0895-4356/06/$ e see front matter  2006 Elsevier Inc. All rights reserved.
doi: 10.1016/j.jclinepi.2006.03.012criteria for good measurement properties are needed to
legitimize what the best questionnaire is.
Several articles offer criteria for the evaluation of ques-
tionnaires. Probably the best-known and most comprehen-
sive criteria are those from the Scientific Advisory
Committee (SAC) of the Medical Outcomes Trust [12]. The
SAC defined eight attributes of instrument properties that
warrant consideration in evaluation. These include (1) con-
ceptual and measurement model, (2) validity, (3) reliability,
(4) responsiveness, (5) interpretability, (6) respondent and
administrative burden, (7) alternative forms, and (8) cultural
and language adaptations (translations). Within each of these
attributes, specific criteria were defined by which instru-
ments should be reviewed. Similar criteria have been defined,
e.g., by Bombardier and Tugwell [13], Andresen [14], and
McDowell and Jenkinson [15]. What is often lacking in these
criteria, however, are explicit criteria for what constitutes
good measurement properties. For example, for the
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eses about expected results should be tested, but no criteria
have been defined for how many hypotheses should be con-
firmed to justify that a questionnaire has good validity. No
criteria have been defined for what constitutes good agree-
ment (acceptable measurement error), good responsiveness,
or good interpretability, and no criteria have been defined
for the required sample size of studies assessing measure-
ment properties.
As suggested by the SAC [12], we took on the challenge
to further discuss and refine the available quality criteria for
studies on the development and evaluation of health status
questionnaires, including explicit criteria for the following
measurement properties: (1) content validity, (2) internal
consistency, (3) criterion validity, (4) construct validity,
(5) reproducibility, (6) responsiveness, (7) floor and ceiling
effects, and (8) interpretability. We used our criteria in two
systematic reviews comparing the measurement properties
of questionnaires for shoulder disability [1] and for visual
functioning [4], and revised them based on our experiences
in these reviews. Our criteria can also be used to detect
shortcomings and gaps in knowledge of measurement
properties, and to design validation studies.
In this article we define our quality criteria for measure-
ment properties, discuss the difficult and sometimes arbi-
trary choices we made, and indicate future challenges.
We emphasize that, just like the criteria offered by the
SAC and others, our criteria are open to further discussion
and refinement. Our aim is to contribute to the development
of explicit quality criteria for the design, methods, and out-
comes of studies on the development and evaluation of
health status questionnaires.
2. Content validity
Content validity examines the extent to which the con-
cepts of interest are comprehensively represented by the
items in the questionnaire [16]. To be able to rate the
quality of a questionnaire, authors should provide a clear
description of the following aspects regarding the develop-
ment of a questionnaire:
e Measurement aim of the questionnaire, i.e., discrimi-
native, evaluative, or predictive [17]. The measure-
ment aim is important, because different items may
be valid for different aims. For example, a question
on stiffness could be a valid item of a discriminative
questionnaire used to measure the impact of osteoar-
thritis on quality of life (to distinguish between pa-
tients with different levels of quality of life), but
would be considered invalid for an evaluative ques-
tionnaire used as an outcome measure in a pain med-
ication trial, because it is unlikely to be changed by
pain medication.
e Target population, i.e., the population for which the
questionnaire was developed. This is important tojudge the relevance and comprehensiveness of the
items. For example, a questionnaire developed to
measure functional status of patients with shoulder
problems may be less valid to measure functional sta-
tus of patients with wrist/hand problems, because
some items may be less relevant for these patients
(e.g., lifting above shoulder level), whereas important
items for patients with wrist/hand problems may be
missing (e.g., buttoning a shirt). The relevance of
items may also depend on disease severity. An ade-
quate description of the target population is therefore
important for judging the comprehensiveness and the
applicability of the questionnaire in (other) populations.
e Concepts that the questionnaire is intended to measure.
To judge the suitability of a questionnaire for a specific
purpose, it is important that authors provide a clear
framework of what the overall concept to be measured
is. Relevant concepts can be defined in terms of symp-
toms; functioning (physical, psychological, and so-
cial); general health perceptions; or overall quality of
life [18]. These different outcome levels should clearly
be distinguished and measured by separate subscales.
For physical functioning it is important to distinguish
between capacity (what a patient thinks he can do)
and performance (what a patient actually does).
e Item selection and item reduction. The methods for
item selection, item reduction, and the execution of
a pilot study to examine the readability and compre-
hension should be justified and reported. Items in the
questionnaire must reflect areas that are important to
the target population that is being studied. Therefore,
the target population should be involved during item
selection. In some guidelines it is recommended that
developers start with a large number of items and apply
item reduction techniques to select a small number of
final items. This strategy, however, does not guarantee
a better content validity, because a comprehensive set
of items can also be achieved without item reduction.
Therefore, we do not consider this to be mandatory.
e Interpretability of the items. Completing the question-
naire should not require reading skills beyond that of
a 12-year-old to avoid missing values and unreliable
answers [19]. That means that items should be short
and simple and should not contain difficult words or
jargon terms. Moreover, items should not consist of
two questions at the same time [19]. Furthermore,
the time period to which the questions refer should
be clearly stated and justified.
We give a positive rating for content validity if a clear
description is provided of the measurement aim, the target
population, the concepts that are being measured, and the
item selection. Furthermore, the target population should
have been involved during item selection, as well as either
investigators or experts. If a clear description is lacking,
content validity is rated as indeterminate.
36 C.B. Terwee et al. / Journal of Clinical Epidemiology 60 (2007) 34e423. Internal consistency
Internal consistency is a measure of the extent to which
items in a questionnaire (sub)scale are correlated (homoge-
neous), thus measuring the same concept. Internal consis-
tency is an important measurement property for
questionnaires that intend to measure a single underlying
concept (construct) by using multiple items. In contrast,
for questionnaires in which the items are merely different
aspects of a complex clinical phenomenon that do not have
to be correlated, such as in the Apgar Scale [20], internal
consistency is not relevant [21,22].
An internally consistent (homogeneous or unidimen-
sional) scale is achieved through good construct definitions,
good items, then principal component analysis or exploratory
factor analysis, followed by confirmatory factor analysis.
When internal consistency is relevant, principal component
analysis or factor analysis should be applied to determine
whether the items form only one overall scale (dimension)
or more than one [23,24]. In case that there is no prior hypoth-
esis regarding the dimensionality of a questionnaire, explor-
atory principal component analysis or factor analyses can be
applied. But if there is a clear hypothesis regarding the factor
structure, e.g., because of an existing theoretical model or be-
cause the factor structure has been determined previously,
confirmatory factor analysis should be used [25,26]. The
number of subjects included in a factor analysis is a matter
of debate. Rules-of-thumb vary from four to 10 subjects
per variable, with a minimum number of 100 subjects to en-
sure stability of the varianceecovariance matrix [27].
After determining the number of (homogeneous) (sub)-
scales, Cronbach’s alpha should be calculated for each
(sub)scale separately. Cronbach’s alpha is considered an ad-
equate measure of internal consistency. A low Cronbach’s
alpha indicates a lack of correlation between the items in
a scale, which makes summarizing the items unjustified.
A very high Cronbach’s alpha indicates high correlations
among the items in the scale, i.e., redundancy of one or
more items. Furthermore, a very high Cronbach’s alpha is
usually found for scales with a large number of items, be-
cause Cronbach’s alpha is dependent upon the number of
items in a scale. Note that Cronbach’s alpha gives no infor-
mation on the number of subscales in a questionnaire, be-
cause alpha can be high when two or more subscales
with high alphas are combined. Nunnally and Bernstein
[28] proposed a criterion of 0.70e0.90 as a measure of
good internal consistency. In our experience, however,
manydin our view goodd(subscales of) questionnaires
have higher Cronbach’s alphas. We give a positive rating
for internal consistency when factor analysis was applied
and Cronbach’s alpha is between 0.70 and 0.95.
4. Criterion validity
Criterion validity refers to the extent to which scores on
a particular instrument relate to a gold standard. We givea positive rating for criterion validity if convincing argu-
ments are presented that the used standard really is ‘‘gold’’
and if the correlation with the gold standard is at least 0.70.
5. Construct validity
Construct validity refers to the extent to which scores on
a particular instrument relate to other measures in a manner
that is consistent with theoretically derived hypotheses con-
cerning the concepts that are being measured [17,19]. Con-
struct validity should be assessed by testing predefined
hypotheses (e.g., about expected correlations between mea-
sures or expected differences in scores between ‘‘known’’
groups). These hypotheses need to be as specific as possi-
ble. Without specific hypotheses, the risk of bias is high be-
cause retrospectively it is tempting to think up alternative
explanations for low correlations instead of concluding that
the questionnaire may not be valid. We therefore give a pos-
itive rating for construct validity if hypotheses are specified
in advance and at least 75% of the results are in correspon-
dence with these hypotheses, in (sub)groups of at least 50
patients.
6. Reproducibility
Reproducibility concerns the degree to which repeated
measurements in stable persons (testeretest) provide simi-
lar answers. We believe that it is important to make a dis-
tinction between reliability and agreement [29,30].
Agreement concerns the absolute measurement error, i.e.,
how close the scores on repeated measures are, expressed
in the unit of the measurement scale at issue. Small mea-
surement error is required for evaluative purposes in which
one wants to distinguish clinically important changes from
measurement error. Reliability concerns the degree to
which patients can be distinguished from each other, de-
spite measurement error [19]. High reliability is important
for discriminative purposes if one wants to distinguish
among patients, e.g., with more or less severe disease (as
in diagnostic applications). Reliability coefficients (intra-
class correlation coefficients (ICC)) concern the variation
in the population (interindividual variation) divided by
the total variation, which is the interindividual variation
plus the intraindividual variation (measurement error),
expressed as a ratio between 0 and 1.
The time period between the repeated administrations
should be long enough to prevent recall, though short
enough to ensure that clinical change has not occurred. Of-
ten, 1 or 2 weeks will be appropriate, but there could be
reasons to choose otherwise. Therefore, we do not rate
the appropriateness of the time period, but only require that
this time period is described and justified.
6.1. Agreement
The measurement error can be adequately expressed
as the standard error of measurement (SEM) [30]. The
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OVA analysis, either including systematic differences
(SEMagreement) or excluding them (SEMconsistency). Many
authors fail to describe how they calculated the SEM. We
believe that systematic differences should be considered
part of the measurement error, because we want to distin-
guish them from ‘‘real’’ changes, e.g., due to treatment.
Therefore, we prefer SEMagreement. The SEM can be con-
verted into the smallest detectable change
(SDC 5 1.96 O2 SEM), which reflects the smallest
within-person change in score that, with P ! 0.05, can be
interpreted as a ‘‘real’’ change, above measurement error,
in one individual (SDCind) [31,32]. The SDC measurable
in a group of people (SDCgroup) can be calculated by
dividing the SDCind by On [32,33].
Another adequate parameter of agreement is described
by Bland and Altman [34]. Their limits of agreement equal
the mean change in scores of repeated measurements
(meanchange) 6 1.96 standard deviation of these changes
(SDchange). The limits of agreement are often reported
because they are easily interpretable. Note that SDchange
equals O2 SEMconsistency.
For evaluative purposes, the absolute measurement error
should be smaller than the minimal amount of change in the
(sub)scale that is considered to be important (minimal im-
portant change (MIC)). Therefore, the MIC of a (sub)scale
should be defined (see under interpretability).
We give a positive rating for agreement if the SDC
(SDCind for application in individuals and SDCgroup for use
in groups) or the limits of agreement (upper or lower limit,
depending on whether the interest is in improvement or de-
terioration) are smaller than the MIC. Because this is a rela-
tively new approach and not yet commonly presented, we
also give a positive rating if authors provide convincing argu-
ments (e.g., based on their experience with the interpretation
of the questionnaire scores) that the agreement is acceptable.
In both cases, we consider a sample size of at least 50 pa-
tients adequate for the assessment of the agreement parame-
ter, based on a general guideline by Altman [35].
6.2. Reliability
The ICC is the most suitable and most commonly used
reliability parameter for continuous measures. Many au-
thors fail to describe which ICC they have used, e.g., an
ICC for consistency (ICCconsistency) or an ICC for agree-
ment (ICCagreement) [19,36]. Because systematic differences
are considered to be part of the measurement error,
ICCagreement (two-way random effects model, or ICC
(A,1) according to McGraw and Wong [36]) is preferred.
The Pearson correlation coefficient is inadequate, because
systematic differences are not taken into account [19].
For ordinal measures, the weighted Cohen’s Kappa coeffi-
cient should be used. The absolute percentage of agreement
is inadequate, because it does not adjust for the agreement
attributable to chance. When quadratic weights are beingused, the weighted Kappa coefficient is identical to the
ICCagreement [19].
Often 0.70 is recommended as a minimum standard for
reliability [28]. We give a positive rating for reliability
when the ICC or weighted Kappa is at least 0.70 in a sample
size of at least 50 patients.
7. Responsiveness
Responsiveness has been defined as the ability of a ques-
tionnaire to detect clinically important changes over time,
even if these changes are small [37]. A large number of def-
initions and methods were proposed for assessing respon-
siveness [38]. We consider responsiveness to be a measure
of longitudinal validity. In analogy to construct validity, lon-
gitudinal validity should be assessed by testing predefined
hypotheses, e.g., about expected correlations between
changes in measures, or expected differences in changes be-
tween ‘‘known’’ groups [38]. This shows the ability of
a questionnaire to measure changes if they really have hap-
pened. Futhermore, the instrument should be able to distin-
guish clinically important change from measurement error.
Responsiveness should therefore be tested by relating the
SDC to the MIC, as described under agreement (see Section
6.1). This approach equals Guyatt’s responsiveness ratio
(RR), in which the clinically important change (MIC) is re-
lated to the between-subject variability in within-subject
changes in stable subjects (SDchange; the same as in the limits
of agreement) [39]. The RR should thus be at least 1.96 (at
the value of 1.96 the MIC equals the SDCind, which is
1.96 SDchange). Another adequate measure of responsive-
ness is the area under the receiver operating characteristics
(ROC) curve (AUC) [40], which is a measure of the ability
of a questionnaire to distinguish patients who have and have
not changed, according to an external criterion. We consider
an AUC of at least 0.70 to be adequate.
8. Floor or ceiling effects
Floor or ceiling effects are considered to be present if
more than 15% of respondents achieved the lowest or high-
est possible score, respectively [41]. If floor or ceiling ef-
fects are present, it is likely that extreme items are
missing in the lower or upper end of the scale, indicating
limited content validity. As a consequence, patients with
the lowest or highest possible score cannot be distinguished
from each other, thus reliability is reduced. Furthermore, the
responsiveness is limited because changes cannot be mea-
sured in these patients. We give a positive rating for (the ab-
sence of) floor and ceiling effects if no floor or ceiling
effects are present in a sample size of at least 50 patients.
9. Interpretability
Interpretability is defined as the degree to which one can
assign qualitative meaning to quantitative scores [42].
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(change in) score would be clinically meaningful. Various
types of information can aid in interpreting scores on
a questionnaire: (1) means and SD of scores of (subgroups
of) a reference population (norm values); (2) means and SD
of scores of relevant subgroups of patients who are ex-
pected to differ in scores (e.g., groups with different clinical
diagnoses, age groups, gender groups, primary vs. second-
ary care setting); (3) means and SD of scores of patients be-
fore and after treatment(s) of known efficacy [43]; and (4)
means and SD of scores of subgroups of patients based on
patients’ global ratings of change. For example, a positive
rating was given if mean scores and SD are presented of
at least four subgroups. For example, if means and SD
are presented for a general population (norm values),
stratified by gender and age groups. In addition, an MIC
should be defined to enable interpretation of change scores
over time and sample size calculations. The MIC has been
defined as ‘‘the smallest difference in score in the domain
of interest which patients perceive as beneficial and would
mandate, in the absence of troublesome side effects and ex-
cessive cost, a change in the patient’s management’’ [44].
Various distribution-based and anchor-based methods have
been proposed. Anchor-based approaches use an external
criterion to operationalize an important change. Distribu-
tion-based approaches are based on statistical characteris-
tics of the sample [45]. We recommend an anchor-based
method, to determine the MIC because distribution-based
methods do not provide a good indication of the importance
of the observed change. We consider a sample size of at
least 50 patients adequate to determine the MIC.
10. Population-specific ratings of measurement
properties
A summary of the criteria for measurement properties of
health status questionnaires is presented in Table 1. Each
property is rated as positive, negative, or indeterminate, de-
pending on the design, methods, and outcomes of the study.
Measurement properties differ between populations and
settings. Therefore, the evaluation of all measurement prop-
erties needs to be conducted in a population and setting that
is representative for the population and setting in which the
questionnaire is going to be used. The setting refers to the
testing conditions, e.g., self-completed or interview, and lan-
guage. A clear description of the design of each individual
study has to be provided, including population (diagnosis
and clinical features, age, and gender); design (e.g., lan-
guage version, time between the measurements, completion
before or after treatment); testing conditions (e.g., question-
naires completed at home or in a waiting room, self of in in-
terview); and analyses of the data. If a clear description of
the design of the study is lacking, the evaluated measure-
ment properties are rated as indeterminate. In addition, if
any important methodological weakness in the design or
execution of the study is found, e.g., selection bias or anextremely heterogeneous study population, the evaluated
measurement properties are also rated as indeterminate.
11. Overview table
In the final comparison of the measurement properties of
different questionnaires, one has to consider all ratings to-
gether when choosing between different questionnaires.
We recommend to compose a table that provides an over-
view of all ratings, such as the example given in Table 2.
In Table 2 the results are presented from our systematic re-
view of all questionnaires measuring disability in patients
with shoulder complaints (because there is no gold standard
for disability, criterion validity was not assessed) [1]. In
Table 2 all ratings for each questionnaire are presented sep-
arately for each specific population or setting. For example,
the Shoulder Pain and Disability Index (SPADI) was eval-
uated in several populations. Construct validity and respon-
siveness were rated positively for outpatients (c), but rated
as indeterminate for primary care patients (b) and hospital
patients (d). With this table one can make an evidence-
based choice for the questionnaire with the best measure-
ment properties, taking into account those measurement
properties that are most important for a specific application
(e.g., reliability when using a questionnaire for discrimina-
tion and responsiveness when using it for evaluation of
a treatment effect) and the population and setting in which
the questionnaire is going to be used.
12. Discussion
We developed quality criteria for the design, methods,
and outcomes of studies on the development and evaluation
of health status questionnaires. Nine measurement proper-
ties were distinguished: content validity, internal consis-
tency, criterion validity, construct validity, reproducibility,
longitudinal validity, responsiveness, floor and ceiling
effects, and interpretability.
Our criteria are mostly opinion based because there is no
empirical evidence in this field to support explicit quality
criteria. They are useful rules of thumb, but other investiga-
tors may want to make their own choices.
We did not summarize the quality criteria into one over-
all quality score, as is often done in systematic reviews of
randomized clinical trials [46]. An overall quality score as-
sumes that all measurement properties are equally impor-
tant, which is probably not the case. We consider content
validity as one of the most important measurement proper-
ties. Only if the content validity of a questionnaire is ade-
quate, one will consider using the questionnaire, and
evaluation of the other measurement properties is useful.
Furthermore, the aim of the questionnaire demands differ-
ent qualities of the questionnaire with respect to reproduc-
ibility and responsiveness. Discriminative questionnaires
require a high level of reliability to be able to distinguish
between persons. Evaluative questionnaires require a high
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Quality criteria for measurement properties of health status questionnaires
Property Definition Quality criteriaa,b
1. Content validity The extent to which the domain of
interest is comprehensively sampled by
the items in the questionnaire
þA clear description is provided of the measurement aim, the target population,
the concepts that are being measured, and the item selection AND target popu-
lation and (investigators OR experts) were involved in item selection;
?A clear description of above-mentioned aspects is lacking OR only target
population involved OR doubtful design or method;
No target population involvement;
0No information found on target population involvement.
2. Internal
consistency
The extent to which items in a (sub)scale
are intercorrelated, thus measuring the
same construct
þFactor analyses performed on adequate sample size (7 * # items and >100)
AND Cronbach’s alpha(s) calculated per dimension AND Cronbach’s alpha(s)
between 0.70 and 0.95;
?No factor analysis OR doubtful design or method;
Cronbach’s alpha(s) !0.70 or O0.95, despite adequate design and method;
0No information found on internal consistency.
3. Criterion validity The extent to which scores on a
particular questionnaire relate to a gold
standard
þConvincing arguments that gold standard is ‘‘gold’’ AND correlation
with gold standard >0.70;
?No convincing arguments that gold standard is ‘‘gold’’ OR doubtful design or
method;
Correlation with gold standard !0.70, despite adequate design and method;
0No information found on criterion validity.
4. Construct validity The extent to which scores on a
particular questionnaire relate to other
measures in a manner that is consistent
with theoretically derived hypotheses
concerning the concepts that are being
measured
þSpecific hypotheses were formulated AND at least 75% of the results are in
accordance with these hypotheses;
?Doubtful design or method (e.g., no hypotheses);
Less than 75% of hypotheses were confirmed, despite adequate design and
methods;
0No information found on construct validity.
5. Reproducibility
5.1. Agreement The extent to which the scores on
repeated measures are close to each
other (absolute measurement error)
þMIC ! SDC OR MIC outside the LOA OR convincing arguments that agreement
is acceptable;
?Doubtful design or method OR (MIC not defined AND no
convincing arguments that agreement is acceptable);
MIC > SDC OR MIC equals or inside LOA, despite adequate design and method;
0No information found on agreement.
5.2. Reliability The extent to which patients can be
distinguished from each other, despite
measurement errors
(relative measurement error)
þICC or weighted Kappa > 0.70;
?Doubtful design or method (e.g., time interval not mentioned);
ICC or weighted Kappa ! 0.70, despite adequate design and method;
0No information found on reliability.
6. Responsiveness The ability of a questionnaire to detect
clinically important changes over time
þSDC or SDC ! MIC OR MIC outside the LOA OR RR O 1.96 OR
AUC > 0.70;
?Doubtful design or method;
SDC or SDC > MIC OR MIC equals or inside LOA OR
RR < 1.96 OR AUC ! 0.70, despite adequate design and methods;
0No information found on responsiveness.
7. Floor and ceiling
effects
The number of respondents who
achieved the lowest or highest possible
score
þ<15% of the respondents achieved the highest or lowest possible scores;
?Doubtful design or method;
O15% of the respondents achieved the highest or lowest possible scores,
despite adequate design and methods;
0No information found on interpretation.
8. Interpretatability The degree to which one can assign
qualitative meaning to quantitative
scores
þMean and SD scores presented of at least four relevant subgroups of patients
and MIC defined;
?Doubtful design or method OR less than four subgroups OR no MIC defined;
0No information found on interpretation.
MIC 5 minimal important change; SDC 5 smallest detectable change; LOA 5 limits of agreement; ICC 5 Intraclass correlation; SD, standard deviation.
a þ5 positive rating; ? 5 indeterminate rating; 5 negative rating; 0 5 no information available.
b Doubtful design or method 5 lacking of a clear description of the design or methods of the study, sample size smaller than 50 subjects (should be at
least 50 in every (subgroup) analysis), or any important methodological weakness in the design or execution of the study.
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ceiling effect InterpretabilityAgreement Reliability
SDQ-UK þ 0 þ 0 0 0 þ (b);  (a) 0
SIQ þ ? þ þ 0 þ þ þ
OSQ þ ? þ þ 0 þ þ þ
SDQ-NL ? 0 þ 0 0 þ (b); ? (b)  (b) þ
RC-QOL þ 0 þ ? 0 0 þ ?
DASH þ 0 þ (c,d); ? (c) þ (c) þ (c) þ (c); ? (d) þ (c) þ
WOSI þ 0 þ 0 þ ? 0 0
SSRS  0 ? (c) ? (d) ? (d) ? (d) þ (d) þ
SRQ þ ? ? ? ? ? 0 ?
SST þ ? þ (c); ? (d) ? (c,d) ? (d) ? (c,d) þ (c) þ
WOOS þ 0 ? 0 ? ? 0 0
SSI 0 0 þ (c) ? (d) ? (d) ? (d) þ (c) 0
UEFS  þ ? 0 0 ? þ þ
ASES  ? þ (c); ? (d) ? (d) ? (c,d) ? (c,d) þ (d); ? (c) þ
SPADI  ? þ (c); ? (b,c) þ (c); ? (d) ? (c,d) þ (c); ? (b,d) þ (b,c) þ
UEFL  0 þ 0 0 0  (a) 0
Rating: þ5 positive; 0 5 intermediate; - 5 poor; ? 5 no information available.
Kinds of study population(s) used in the studies: (a) community, (b) primary care, (c) outpatients’ clinic, and (d) hospital patients.
SDQ-UK 5 Shoulder Disability Questionnaire (English version); SIQ 5 Shoulder Instability Questionnaire; OSQ (Oxford) 5 Shoulder Questionnaire;
SDQ-NL 5 Shoulder Disability Questionnaire (Dutch version); RC-QOL 5 Rotator Cuff Quality-of-Life Measure; DASH 5 Disabilities of the Arm, Shoul-
der and Hand Scale; WOSI 5 Western Ontario Shoulder Instability Index; SSRS 5 Subjective Shoulder Rating Scale; SST 5 Simply Shoulder Test;
SSI 5 Shoulder Severity Index; UEFS 5 Upper Extremity Function Scale; ASES 5 American Shoulder and Elbow Surgeons Standardized Shoulder Assess-
ment Form.level of agreement to be able to measure important
changes. Evaluative questionnaires should be responsive
to change, whereas discriminative questionnaires do not
necessarily need to be responsive to change.
We recommend to always compose a table that provides
an overview of all ratings of all questionnaires, such as Ta-
ble 2, which facilitates an assessment of all ratings together
when choosing the most suitable questionnaire for a specific
application. Two important issues should be kept in mind.
Firstly, with our approach, poor quality questionnaires
can be given positive ratings for some measurement proper-
ties. For example, the Upper Extremity Functional Limita-
tion Scale (UEFL) received a positive rating for construct
validity despite a negative rating for content validity. By
considering all ratings together, one may decide for exam-
ple to choose the Shoulder Rating Questionnaire (SRQ) or
the Western Ontario Osteoarthritis of the Shoulder Index
(WOOS), with positive ratings for content validity, over
the UEFL, despite the fact that these questionnaires re-
ceived indeterminate ratings for construct validity. Sec-
ondly, questionnaires with the highest number of positive
ratings are not necessarily the best questionnaires. The rat-
ings depend on the availability of information and the qual-
ity of reporting on the assessment of the measurement
properties. For example, a questionnaire can be given many
indeterminate ratings if measurement properties are not yet
evaluated because the questionnaire is newly developed.
Furthermore, poorly reported validation studies will lead
to low ratings for questionnaires that are not necessarily
poor in design or performance. The quality of reportingof studies on the development and evaluation of health sta-
tus questionnaires therefore needs to be improved.
In applying our criteria in two systematic reviews [1,4],
we found that several measurement properties are often not
properly assessed or analyzed, nor clearly reported. Impor-
tant information on content validity is often very limited.
The aim of a questionnaire, i.e., whether the questionnaire
was designed for discriminative or evaluative purposes, is
often not described, and the concepts that the questionnaire
is intended to measure are often ill defined. Furthermore,
item selection is often poorly described. A statement like
‘‘A preliminary questionnaire was developed and com-
pleted by 30 patients.. A subset of these patients was in-
terviewed and each question was assessed for clinical
relevance, importance, and ease of completion’’ [47] does
not justify that the items comprehensively represent all is-
sues that are important to the target population. This ham-
pers judgment about the applicability of the questionnaire
in a given population.
One would assume that the number of scales corre-
sponds with the number of dimensions identified in factor
analysis, but this is often not the case. We found that sev-
eral questionnaires claimed to cover more than one dimen-
sion, but consisted of one scale only, or vice versa [1].
Many authors fail to specify hypotheses for the assess-
ment of construct validity or the hypotheses are not very
specific or informative. For example, to validate a shoulder
disability questionnaire, the authors tested the hypothesis
that ‘‘restriction of shoulder movement on examination
correlates with disability score’’ [48]. An informative
41C.B. Terwee et al. / Journal of Clinical Epidemiology 60 (2007) 34e42hypothesis should evaluate, as directly as possible, specific
claims made for a theory [49], and should thus include a jus-
tification of the expected direction and magnitude of the
correlation. Without testing specific hypotheses, the risk
of bias is high. Practically all authors of instrument evalu-
ation studies conclude that their instrument is valid,
whereas objective counting of the number of hypotheses
that were confirmed frequently indicates otherwise [1,4].
Responsiveness is often ill defined and not well as-
sessed. For example, many authors use multiple indices
of responsiveness and conclude that their instrument is re-
sponsive when all indices point in the same direction
[50e52]. Different authors, however, have pointed to the
conceptual and algebraic differences between different in-
dices of responsiveness, showing that different indices
may lead to different conclusions [53,54]. Furthermore,
many indices of responsiveness should actually be looked
upon as measures of the magnitude of a treatment effect,
which, in itself, tell us nothing about the quality of the in-
strument to serve its purpose [38].
We recommend using criteria like ours as an aid in the
design and reporting of studies on the development and
evaluation of health status questionnaires. This should lead
to an improvement in the quality of (reporting of) such
studies.
13. Future challenges
One might argue that our criteria are not discriminative
enough to distinguish between good and very high-quality
questionnaires. This would be important when many
high-quality questionnaires are available, but in our experi-
ence, within the field of health status and health-related
quality of life measurement, this is not (yet) the case.
Therefore, we believe that our criteria work well to separate
the wheat from the chaff. The next step would be to further
refine and complete the criteria, e.g., by deciding how spe-
cific the hypotheses for testing construct validity or respon-
siveness should be, and by including criteria for the
methods and results of studies using Item Response Theory
(IRT) models. Furthermore, broad consensus is needed, es-
pecially on the criteria for good measurement properties.
Because the number of health status questionnaires is
rapidly growing, choosing the right questionnaire for a spe-
cific purpose becomes a time-consuming and difficult task.
An increasing number of systematic reviews are being pub-
lished in which the measurement properties of health status
questionnaires are being evaluated and compared. These
systematic reviews are important tools for evidence-based
instrument selection. Explicit quality criteria for studies
on the development and evaluation of health status ques-
tionnaires are needed to legitimize what the best question-
naire is. Our criteria are a step in this direction. The future
challenge will be to refine and complete the criteria and to
reach broad consensus, especially on the quality criteria for
good measurement properties.References
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